US 7,494,648 B2
	Cancerous disease modifying antibodies
David S. F. Young, Toronto (Canada); Susan E. Hahn, Toronto (Canada); and Lisa M. Cechetto, Ancaster (Canada)
Assigned to Hoffmann-La Roche Inc., Nutley, N.J. (US)
Filed on Jul. 31, 2006, as Appl. No. 11/496,672.
Claims priority of provisional application 60/705242, filed on Aug. 02, 2005.
Prior Publication US 2007/0031330 A1, Feb. 08, 2007
Int. Cl. A61K 39/395 (2006.01); A61K 51/00 (2006.01); C07K 16/30 (2006.01); G01N 33/574 (2006.01)

U.S. Cl. 424—133.1  [424/1.49; 424/155.1; 435/7.23; 530/338.8]

16 Claims

1. The isolated monoclonal antibody produced by the hybridoma deposited with the IDAC as accession number 170505-05.